General
publicado em 05/10/2012 às 12h23:00
   Dê o seu voto:

Created in Brazil, malaria drug becomes a global benchmark

Medication was certified by WHO, which will allow it to be offered by international organizations such as UNICEF

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Farmanguinhos/Fiocruz
Treatment is a mixture of fixed-dose artesunate (AS) and mefloquine (MQ) being developed by the Institute Farmaguinhos Fiocruz
  « Previous
next »  
Treatment is a mixture of fixed-dose artesunate (AS) and mefloquine (MQ) being developed by the Institute Farmaguinhos Fiocruz

A drug developed in Brazil will expand its role as an ally in the fight against malaria in Asia. This is the fixed-dose combination of artesunate (AS) and mefloquine (MQ) treatment against the disease originally developed by Farmaguinhos, Fiocruz institute, in partnership with the organization of research and development non-profit Drugs for Neglected Diseases initiative (DNDi , its acronym in English).

The remedy has been certified by the World Health Organization (WHO) this week, becoming a reference in the world. The recognition also enables it to be offered by organizations that receive funding from international organizations such as UNICEF and the Global Fund to fight Aids, Tuberculosis and Malaria.

The drug is already registered in Malaysia and India, and is currently manufactured in the facilities of pharmaceutical company Cipla, the Indian region of Patalganga. Access to medicine in Asia was facilitated by the transfer of technology to Farmanguinhos Cipla in 2010. The institution provided both specialists to transfer control techniques for product quality and for its manufacture.

The so-called "pre-qualification" WHO - only program of quality assurance of medicines in the world - allows the medicine to be more easily acquired in Southeast Asia, which represents a major step toward universal treatment of the disease.

<i> information Fiocruz </ i>

Source: Isaude.net
   Palavras-chave:   Malaria    Drug    Drugs for Neglected Diseases    DNDi    Farmanguinhos    Fiocruz    Oswaldo Cruz Foundation   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Created in Brazil, malaria drug becomes a global benchmark
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Created in Brazil, malaria drug becomes a global benchmark


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
Malaria    drug    Drugs for Neglected Diseases    DNDi    Farmanguinhos    Fiocruz    Oswaldo Cruz Foundation   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.